Pain on injection: A double-blind comparison of propofol with lidocaine pretreatment versus propofol formulated with long- and medium-chain triglycerides

被引:36
作者
Schaub, E [1 ]
Kern, C [1 ]
Landau, R [1 ]
机构
[1] Hop Cantonal Univ Geneva, Anesthesiol Serv, Dept APSIC, CH-1211 Geneva 14, Switzerland
关键词
D O I
10.1213/01.ANE.0000136848.54207.97
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The incidence of pain on injection of propofol has been reported to be 70%. A new propofol formulation with a 10% emulsion of long-and medium-chain triglycerides (LCT/MCT) is associated with less pain on injection. Our goal was to compare the effect of propofol-LCT/ MCT on the incidence of pain versus propofol with lidocaine 40 mg TV pretreatment injected as a Bier's block. Two hundred healthy women scheduled for ambulatory gynecological procedures were allocated to 1 of 2 groups in a randomized double-blind fashion. Group LIDO received lidocaine 2% 2 ml, injected with a tourniquet 1 min before propofol 1% 2 mg/kg IV; group LCT/MCT received NaCl 0.9% 2 mL with tourniquet 1 min before propofol-LCT/MCT 1% 2 mg/kg IV. Spontaneous verbal expressions of pain, movement of hand, frowning, and moaning during the injection were recorded. The incidence and severity of pain were assessed 30 min and 6 h after surgery. Recall of pain was considered with a visual analog scale (VAS) score >1, and pain was graded as VAS 0-10. More women reported spontaneous verbal expression of pain with propofol-LCT/MCT (47% versus 24%; P = 0.0014; relative risk 1.61 [95% confidence interval, 1.22-2.13]). Among women with a painful injection, there was no difference after surgery regarding the intensity of pain or recall of pain. In contrast to previous reports, we found that propofol-LCT/MCT resulted in a more frequent incidence of pain than propofol 1% with IV lidocaine pretreatment. This may be due to the diversity of pain definitions used in studies or to the lack of premedication in our study.
引用
收藏
页码:1699 / 1702
页数:4
相关论文
共 14 条
[1]  
Bachmann-Mennenga B, 2003, ARZNEIMITTEL-FORSCH, V53, P621
[2]   Reducing pain during propofol injection: The role of the solvent [J].
Doenicke, AW ;
Roizen, MF ;
Rau, J ;
Kellermann, W ;
Babl, J .
ANESTHESIA AND ANALGESIA, 1996, 82 (03) :472-474
[3]   Pharmacokinetics and pharmacodynamics of propofol in a new solvent [J].
Doenicke, AW ;
Roizen, MF ;
Rau, J ;
OConnor, M ;
Kugler, J ;
Klotz, U ;
Babl, J .
ANESTHESIA AND ANALGESIA, 1997, 85 (06) :1399-1403
[4]   PAIN ON INJECTION OF PROPOFOL - METHODS OF ALLEVIATION [J].
JOHNSON, RA ;
HARPER, NJN ;
CHADWICK, S ;
VOHRA, A .
ANAESTHESIA, 1990, 45 (06) :439-442
[5]  
Kunitz O, 2004, ANASTH INTENSIV NOTF, V39, P10
[6]  
Larsen B, 2001, ANAESTHESIST, V50, P842, DOI 10.1007/s00101-001-0234-0
[7]  
Larsen R, 2001, ANAESTHESIST, V50, P676, DOI 10.1007/s001010100213
[8]   Profound pain due to propofol injection triggered myocardial ischemia in a patient with a suspected pheochromocytoma [J].
Morishima, T ;
Sobue, K ;
Arima, H ;
Tanaka, S ;
So, MH ;
Ando, H ;
Katsuya, H .
ANESTHESIA AND ANALGESIA, 2003, 96 (02) :631-631
[9]   Prevention of pain on injection of propofol: A comparison of lidocaine with alfentanil [J].
Nathanson, MH ;
Gajraj, NM ;
Russell, JA .
ANESTHESIA AND ANALGESIA, 1996, 82 (03) :469-471
[10]  
Picard P, 2000, ANESTH ANALG, V90, P963